Rangaprasad Sarangarajan

As CSO and SVP of Clinical and Translational Sciences at BERG, Ranga led multi-functional teams integrating biology, technology, and artificial intelligence analytics to develop a multi-omic, biology-based platform for the discovery of disease-specific and therapeutic targets and diagnostics development. Those efforts established a robust pipeline of assets targeting various diseases and indications, leading several programs through early IND, enabling a First-In-Human Phase 1 and proof-concept Phase 2 clinical program. Ranga obtained his Ph.D. in Pharmaceutical Sciences from the University of Cincinnati and a B.S. in Pharmacy from Maharaja Sayajirao University.